当前蛋白身份:Q08602 重新检索
本组结构的主要差异维度
构建体不同 突变/修饰不同 组装状态不同 配体/离子不同 实验环境不同 结构质量指标不同

差异标签只比较当前检索结果;所有PDB和assembly原始记录仍分别保留。

相关结构差异明细

一行代表一个 PDB 条目中的一个 biological assembly;同一蛋白的多个单体会分别列出。

PDB 条目 Assembly / 聚集状态 构建体 突变与修饰 配体、离子与非聚合物 实验方法 实验环境 结构质量
1DCE CRYSTAL STRUCTURE OF RAB GERANYLGERANYLTRANSFERASE FROM RAT BRAIN 提交 1999-11-04 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–567(567 aa)
非标准单体:是(mmCIF未提供具体位点) ZN ZINC ION × 1 X-RAY DIFFRACTION mmCIF 未提供已读取条件 分辨率 2.00 Å R-free 0.263
1DCE CRYSTAL STRUCTURE OF RAB GERANYLGERANYLTRANSFERASE FROM RAT BRAIN 提交 1999-11-04 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 1–567(567 aa)
非标准单体:是(mmCIF未提供具体位点) ZN ZINC ION × 1 X-RAY DIFFRACTION mmCIF 未提供已读取条件 分辨率 2.00 Å R-free 0.263
1LTX Structure of Rab Escort Protein-1 in complex with Rab geranylgeranyl transferase and isoprenoid 提交 2002-05-21 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 1–567(567 aa)
未记录 ZN ZINC ION × 1 CL CHLORIDE ION × 1 FAR FARNESYL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.2;298 K;20% PEG 3350, 100mM KSCN, 100mM Namalonate, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K
分辨率 2.70 Å R-free 0.272
3C72 Engineered RabGGTase in complex with a peptidomimetic inhibitor 提交 2008-02-06 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–236(236 aa)
链 A 353–441(89 aa)
未记录 ZN ZINC ION × 1 CA CALCIUM ION × 1 CX1 N-[(benzyloxy)carbonyl]-L-histidyl-N-methyl-L-phenylalanyl-L-tyrosine × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.2;284 K;14% (w/v) PEG 3350, 0.2 M Ca-Acetate, 0.1 M HEPES, cocrystallization with 5 mM inhibitor, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 284K
分辨率 2.30 Å R-free 0.256
3DSS Crystal structure of RabGGTase(DELTA LRR; DELTA IG) 提交 2008-07-14 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–237(237 aa) 片段:PFTA domains, UNP residues 1-237 and 353-441
链 A 353–441(89 aa) 片段:PFTA domains, UNP residues 1-237 and 353-441
未记录 ZN ZINC ION × 1 CA CALCIUM ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.2;284 K;14% (w/v) PEG 3350, 0.2M Ca(OAc)2, 0.1M HEPES, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 284K
分辨率 1.80 Å R-free 0.194
3DST Crystal structure of RabGGTase(DELTA LRR; DELTA IG)in complex with geranylgeranyl pyrophosphate 提交 2008-07-14 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–237(237 aa) 片段:PFTA domains, UNP residues 1-237 and 353-441
链 A 353–441(89 aa) 片段:PFTA domains, UNP residues 1-237 and 353-441
未记录 GRG GERANYLGERANYL DIPHOSPHATE × 1 ZN ZINC ION × 1 CA CALCIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.2;284 K;14% (w/v) PEG 3350, 0.2M Ca(OAc)2, 0.1M HEPES, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 284K
分辨率 1.90 Å R-free 0.220
3DSU Crystal structure of RabGGTase(DELTA LRR; DELTA IG)in complex with farnesyl pyrophosphate 提交 2008-07-14 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–237(237 aa) 片段:PFTA domains, UNP residues 1-237 and 353-441
链 A 353–441(89 aa) 片段:PFTA domains, UNP residues 1-237 and 353-441
未记录 FPP FARNESYL DIPHOSPHATE × 1 ZN ZINC ION × 1 CA CALCIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.2;284 K;14% (w/v) PEG 3350, 0.2M Ca(OAc)2, 0.1M HEPES, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 284K
分辨率 1.90 Å R-free 0.215
3DSV Crystal structure of RabGGTase(DELTA LRR; DELTA IG)in complex with mono-prenylated peptide Ser-Cys-Ser-Cys(GG) derivated from Rab7 提交 2008-07-14 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–237(237 aa) 片段:PFTA domains, UNP residues 1-237 and 353-441
链 A 353–441(89 aa) 片段:PFTA domains, UNP residues 1-237 and 353-441
未记录 ZN ZINC ION × 1 CA CALCIUM ION × 1 GER GERAN-8-YL GERAN × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.2;284 K;14% (w/v) PEG 3350, 0.2M Ca(OAc)2, 0.1M HEPES, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 284K
分辨率 2.10 Å R-free 0.211
3DSW Crystal structure of RabGGTase(DELTA LRR; DELTA IG)in complex with mono-prenylated peptide Ser-Cys(GG)-Ser-Cys derivated from Rab7 提交 2008-07-14 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–237(237 aa) 片段:PFTA domains, UNP residues 1-237 and 353-441
链 A 353–441(89 aa) 片段:PFTA domains, UNP residues 1-237 and 353-441
未记录 ZN ZINC ION × 1 CA CALCIUM ION × 1 GER GERAN-8-YL GERAN × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.2;284 K;14% (w/v) PEG 3350, 0.2M Ca(OAc)2, 0.1M HEPES, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 284K
分辨率 2.15 Å R-free 0.232
3DSX Crystal structure of RabGGTase(DELTA LRR; DELTA IG)in complex with di-prenylated peptide Ser-Cys(GG)-Ser-Cys(GG) derivated from Rab7 提交 2008-07-14 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–237(237 aa) 片段:PFTA domains, UNP residues 1-237 and 353-441
链 A 353–441(89 aa) 片段:PFTA domains, UNP residues 1-237 and 353-441
未记录 ZN ZINC ION × 1 CA CALCIUM ION × 1 GER GERAN-8-YL GERAN × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.2;284 K;14% (w/v) PEG 3350, 0.2M Ca(OAc)2, 2.5% (v/v)DMSO, 0.1M HEPES, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 284K
分辨率 2.10 Å R-free 0.229
3HXB Engineered RabGGTase in complex with a peptidomimetic inhibitor (compound 6) 提交 2009-06-20 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–237(237 aa) 片段:RabGGTase ALPHA-subunit
链 A 353–441(89 aa) 片段:RabGGTase ALPHA-subunit
突变:DELTA LRR; DELTA IG 突变:DELTA LRR; DELTA IG BD5 N-[(benzyloxy)carbonyl]-D-tyrosyl-L-phenylalanyl-L-tyrosine × 1 ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.2;284 K;14% (w/v) PEG3350, 0.2 M Ca(OAc)2, 0.1 M HEPES, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 284K
分辨率 2.25 Å R-free 0.278
3HXC Engineered RabGGTase in complex with a peptidomimetic inhibitor (compound 8) 提交 2009-06-20 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–237(237 aa) 片段:RabGGTase ALPHA-subunit
链 A 353–441(89 aa) 片段:RabGGTase ALPHA-subunit
突变:DELTA LRR; DELTA IG 突变:DELTA LRR; DELTA IG ZN ZINC ION × 1 CA CALCIUM ION × 1 BD6 N-[(benzyloxy)carbonyl]-L-histidyl-N-methyl-L-phenylalanyl-N-hydroxy-L-tryptophanamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.2;284 K;14% (w/v) PEG3350, 0.2 M Ca(OAc)2, 0.1 M HEPES, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 284K
分辨率 1.95 Å R-free 0.218
3HXD Engineered RabGGTase in complex with a peptidomimetic inhibitor (compound 9) 提交 2009-06-20 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–237(237 aa) 片段:RabGGTase ALPHA-subunit
链 A 353–441(89 aa) 片段:RabGGTase ALPHA-subunit
突变:DELTA LRR; DELTA IG 突变:DELTA LRR; DELTA IG ZN ZINC ION × 1 CA CALCIUM ION × 1 BD7 N-[(benzyloxy)carbonyl]-L-histidyl-N-methyl-L-phenylalanyl-N-hydroxy-L-tyrosinamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.2;284 K;14% (w/v) PEG3350, 0.2 M Ca(OAc)2, 0.1 M HEPES, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 284K
分辨率 1.95 Å R-free 0.222
3HXE Engineered RabGGTase in complex with a peptidomimetic inhibitor (compound 37) 提交 2009-06-20 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–237(237 aa) 片段:RabGGTase ALPHA-subunit
链 A 353–441(89 aa) 片段:RabGGTase ALPHA-subunit
突变:DELTA LRR; DELTA IG 突变:DELTA LRR; DELTA IG ZN ZINC ION × 1 CA CALCIUM ION × 1 BD8 N-undecanoyl-L-histidyl-L-phenylalanyl-N-methyl-N-(2-pyridin-2-ylethyl)-L-tyrosinamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.2;284 K;14% (w/v) PEG3350, 0.2 M Ca(OAc)2, 0.1 M HEPES, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 284K
分辨率 1.95 Å R-free 0.215
3HXF Engineered RabGGTase in complex with a peptidomimetic inhibitor (compound 32) 提交 2009-06-20 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–237(237 aa) 片段:RabGGTase ALPHA-subunit
链 A 353–441(89 aa) 片段:RabGGTase ALPHA-subunit
突变:DELTA LRR; DELTA IG 突变:DELTA LRR; DELTA IG ZN ZINC ION × 1 CA CALCIUM ION × 1 BD9 N-undecanoyl-L-histidyl-L-histidyl-N-methyl-N-(2-pyridin-2-ylethyl)-L-tyrosinamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.2;284 K;14% (w/v) PEG3350, 0.2 M Ca(OAc)2, 0.1 M HEPES, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 284K
分辨率 1.90 Å R-free 0.212
3PZ1 Crystal structure of RabGGTase(DELTA LRR; DELTA IG) in Complex with BMS3 提交 2010-12-14 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–237(237 aa) 片段:Fusion of residues 1-237 and 353-441 with linker AGSG
链 A 353–441(89 aa) 片段:Fusion of residues 1-237 and 353-441 with linker AGSG
未记录 3PZ (3R)-3-benzyl-4-[(4-methoxyphenyl)sulfonyl]-1-[(1-methyl-1H-imidazol-5-yl)methyl]-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-7-carbonitrile × 1 ZN ZINC ION × 1 CA CALCIUM ION × 1 DMS DIMETHYL SULFOXIDE × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.2;284 K;14% (w/v) PEG3350, 0.2 M Ca(OAc)2, 0.1 M HEPES, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 284K
分辨率 1.95 Å R-free 0.232
3PZ2 Crystal structure of RabGGTase(DELTA LRR; DELTA IG) in Complex with BMS3 and lipid substrate GGPP 提交 2010-12-14 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–237(237 aa) 片段:UNP residues 1-237 and 353-441
链 A 353–441(89 aa) 片段:UNP residues 1-237 and 353-441
未记录 ZN ZINC ION × 1 CA CALCIUM ION × 1 3PZ (3R)-3-benzyl-4-[(4-methoxyphenyl)sulfonyl]-1-[(1-methyl-1H-imidazol-5-yl)methyl]-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-7-carbonitrile × 1 GRG GERANYLGERANYL DIPHOSPHATE × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.2;284 K;14% (w/v) PEG3350, 0.2 M Ca(OAc)2, 0.1 M HEPES, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 284K
分辨率 2.35 Å R-free 0.256
3PZ3 Crystal structure of RabGGTase(DELTA LRR; DELTA IG) in Complex with BMS-analogue 14 提交 2010-12-14 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–237(237 aa) 片段:UNP residues 1-237 and 353-441
链 A 353–441(89 aa) 片段:UNP residues 1-237 and 353-441
未记录 ZN ZINC ION × 1 CA CALCIUM ION × 1 PZ3 4-({(3R)-7-(5-formylfuran-2-yl)-4-[(4-methoxyphenyl)sulfonyl]-1-[(1-methyl-1H-imidazol-5-yl)methyl]-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl}methyl)phenyl benzylcarbamate × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.2;284 K;14% (w/v) PEG3350, 0.2 M Ca(OAc)2, 0.1 M HEPES, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 284K
分辨率 2.00 Å R-free 0.224
4EHM RabGGTase in complex with covalently bound Psoromic acid 提交 2012-04-02 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–237(237 aa)
链 A 353–441(89 aa)
未记录 PJA 4-formyl-3-hydroxy-8-methoxy-1,9-dimethyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepine-6-carboxylic acid × 1 ZN ZINC ION × 1 CA CALCIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.2;285 K;20mM Hepes pH7.2, 100mM NaCl, 2mM DTT, 15% PEG 3350, 0.2M Ca Acetate, 0.1M Hepes pH7.2, VAPOR DIFFUSION, HANGING DROP, temperature 285K
分辨率 2.20 Å R-free 0.251
4GTS Engineered RabGGTase in complex with BMS analogue 16 提交 2012-08-29 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–237(237 aa) 片段:residues 1-237 and 353-441 linked with AGSG
链 A 353–441(89 aa) 片段:residues 1-237 and 353-441 linked with AGSG
未记录 ZN ZINC ION × 1 CA CALCIUM ION × 1 7TP 5-{(3R)-3-(4-hydroxybenzyl)-4-[(4-methoxyphenyl)sulfonyl]-1-[(1-methyl-1H-imidazol-5-yl)methyl]-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-7-yl}furan-2-carbaldehyde × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.2;285 K;RabGGTase in 20mM Hepes pH7.2, 100mM NaCl and 2mM DTT was mixed with 15% PEG3350, 0.2M Ca Acetate, 0.1M Hepes pH7.2. The obtained crystals was soaked with 20% PEG3350, 0.2M Ca Acetate, 5% Glycerol in the presence of 1mM inhibitor for 12 hour, VAPOR DIFFUSION, HANGING DROP, temperature 285K
分辨率 2.45 Å R-free 0.248
4GTT Engineered RabGGTase in complex with BMS analogue 12 提交 2012-08-29 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–237(237 aa) 片段:residues 1-237 and 353-441 linked with AGSG
链 A 353–441(89 aa) 片段:residues 1-237 and 353-441 linked with AGSG
未记录 ZN ZINC ION × 1 CA CALCIUM ION × 1 7TQ 4-({(3R)-7-cyano-4-[(4-methoxyphenyl)sulfonyl]-1-[(1-methyl-1H-imidazol-5-yl)methyl]-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl}methyl)phenyl benzylcarbamate × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.2;285 K;RabGGTase in 20mM Hepes pH7.2, 100mM NaCl and 2mM DTT was mixed with 15% PEG3350, 0.2M Ca Acetate, 0.1M Hepes pH7.2. The obtained crystals was soaked with 20% PEG3350, 0.2M Ca Acetate, 5% Glycerol in the presence of 1mM inhibitor for 12 hour., VAPOR DIFFUSION, HANGING DROP, temperature 285K
分辨率 2.05 Å R-free 0.233
4GTV Engineered RabGGTase in complex with BMS analogue 13 提交 2012-08-29 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–237(237 aa) 片段:residues 1-237 and 353-441 linked with AGSG
链 A 353–441(89 aa) 片段:residues 1-237 and 353-441 linked with AGSG
未记录 ZN ZINC ION × 1 CA CALCIUM ION × 1 7TR 4-({(3R)-7-cyano-4-[(4-methoxyphenyl)sulfonyl]-1-[(1-methyl-1H-imidazol-5-yl)methyl]-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl}methyl)phenyl diethylcarbamate × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.2;285 K;RabGGTase in 20mM Hepes pH7.2, 100mM NaCl and 2mM DTT was mixed with 15% PEG3350, 0.2M Ca Acetate, 0.1M Hepes pH7.2. The obtained crystals was soaked with 20% PEG3350, 0.2M Ca Acetate, 5% Glycerol in the presence of 1mM inhibitor for 12 hour, VAPOR DIFFUSION, HANGING DROP, temperature 285K
分辨率 1.95 Å R-free 0.211